GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > Please Correct me if I’m wrong.

<< Previous

Bullboard Posts

Next >>

Comment by madInvestingon Dec 01, 2017 3:08pm

171 Views

Post# 27074527

RE:RE:Please Correct me if I’m wrong.

Rockpaperstock wrote: It depends on the 20 day VWAP of ACB"s share price at the time the deal goes through. Let's say the VWAP happens to be today's price (@ $7.71 this very moment). You would get $24 / $7.71 = 3.11 shares of ACB per share of CMED. Meaning for 1,000 CMED shares, you'd get 3,113 ACB shares. Based on the amount you would have sold your CMED shares for ($19,070), you'd be getting $4,930 extra in ACB shares.

That's how I read the offer. It says we'd be getting 4.53 ACB shares per CMED share, BUT if 4.53 x the 20 day VWAP of ACB exceeds $24 per CMED share, the new ratio gets calculated as $24 / the VWAP.

If you sold all your CMED shares right now and bought ACB before the deal, for $7.71 / ACB share you'd get 2,473 ACB shares, 640 fewer than if the deal went through.

Hope I'm right. The Orb can confirm lol.

That is correct. We would get 3.11 shares for each CMED share if the 20 day average was $7.71. The problem with waiting until March is the price will likely be much higher and as soon as we get those ACB shares they will drop because of how diluted they have become. The real question is do you sell CMED now and buy ACB and then sell right before the merger which should be when it's at its high or hope that CMED somehow gets a better deal with ACB?